Table 2.
Cerebellar grey matter | Estimated marginal mean±SE for groups | Statistics | |||||
Controls, n=110 | ALS-NEG, n=133 | ALS-C9, n=22 | Univariate effect size | HC vs ALS-NEG | HC vs ALS-C9 | ||
Left lobules* |
I–II | 0.030±0.001 | 0.029±0.001 | 0.030±0.002 | η2p=0.000 | 1.000 | 1.000 |
III | 0.505±0.011 | 0.483±0.010 | 0.518±0.026 | η2p=0.011 | 0.484 | 1.000 | |
IV | 2.080±0.029 | 1.984±0.026 | 1.844±0.065 | η2p=0.049 | 0.045 | 0.003 | |
V | 3.590±0.047 | 3.612±0.042 | 3.394±0.106 | η2p=0.014 | 1.000 | 0.276 | |
VI | 7.880±0.101 | 7.946±0.092 | 7.822±0.231 | η2p=0.001 | 1.000 | 1.000 | |
VIIB | 4.031±0.059 | 3.944±0.054 | 3.782±0.135 | η2p=0.012 | 0.851 | 0.286 | |
VIIIA | 4.921±0.062 | 5.017±0.057 | 5.015±0.142 | η2p=0.005 | 0.767 | 1.000 | |
VIIIB | 3.334±0.053 | 3.476±0.048 | 3.294±0.121 | η2p=0.018 | 0.155 | 1.000 | |
IX | 2.672±0.045 | 2.719±0.041 | 2.638±0.102 | η2p=0.003 | 1.000 | 1.000 | |
X | 0.584±0.007 | 0.573±0.007 | 0.592±0.017 | η2p=0.007 | 0.816 | 1.000 | |
Crus I | 11.106±0.153 | 10.760±0.140 | 10.371±0.350 | η2p=0.019 | 0.300 | 0.169 | |
Crus II | 6.893±0.099 | 6.782±0.090 | 6.551±0.225 | η2p=0.008 | 1.000 | 0.500 | |
Right lobules† |
I–II | 0.035±0.001 | 0.037±0.001 | 0.039±0.002 | η2p=0.012 | 0.711 | 0.305 |
III | 0.495±0.010 | 0.480±0.009 | 0.506±0.024 | η2p=0.006 | 0.896 | 1.000 | |
IV | 1.950±0.029 | 1.846±0.027 | 1.891±0.067 | η2p=0.025 | 0.030 | 1.000 | |
V | 3.317±0.045 | 3.349±0.041 | 3.214±0.103 | η2p=0.006 | 1.000 | 1.000 | |
VI | 7.873±0.102 | 7.892±0.093 | 7.519±0.233 | η2p=0.009 | 1.000 | 0.495 | |
VIIB | 4.210±0.061 | 4.089±0.056 | 3.852±0.140 | η2p=0.023 | 0.450 | 0.061 | |
VIIIA | 4.821±0.064 | 4.906±0.058 | 4.691±0.146 | η2p=0.009 | 0.980 | 1.000 | |
VIIIB | 3.411±0.058 | 3.505±0.053 | 3.370±0.133 | η2p=0.007 | 0.708 | 1.000 | |
IX | 2.836±0.045 | 2.893±0.041 | 2.809±0.102 | η2p=0.004 | 1.000 | 1.000 | |
X | 0.582±0.007 | 0.566±0.007 | 0.588±0.017 | η2p=0.013 | 0.292 | 1.000 | |
Crus I | 11.108±0.149 | 10.797±0.136 | 10.566±0.340 | η2p=0.013 | 0.380 | 0.436 | |
Crus II | 7.088±0.103 | 6.954±0.094 | 6.985±0.235 | η2p=0.004 | 1.000 | 1.000 |
Estimated marginal mean±SE for grey matter volumes adjusted for age, gender and total intracranial volume.
Bold p values are significant at p<0.05 after Bonferroni correction for multiple comparisons.
Partial η2 effect size is interpreted as small (η2p=0.01), medium (η2p=0.06) or large (η2p=0.14).
*Wilks’ lambda=0.854; F=1.695; p=0.022; η2p=0.076.
†Wilks’ lambda=0.857; F=1.662; p=0.026; η2p=0.074.
ALS, amyotrophic lateral sclerosis; ALS-C9, patients who tested positive for GGGGCC repeat expansions in C9orf72; ALS-NEG, patients who tested negative for both ATXN2 and C9orf72; HC, healthy control.